TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $122,000 | +19.6% | 90,676 | 0.0% | 0.00% | – |
| Q4 2018 | $102,000 | -53.0% | 90,676 | +15.2% | 0.00% | – |
| Q3 2018 | $217,000 | -22.8% | 78,713 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $281,000 | +16.1% | 78,713 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $242,000 | -52.2% | 78,713 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $506,000 | -8.0% | 80,262 | -0.3% | 0.00% | 0.0% |
| Q3 2017 | $550,000 | +15.1% | 80,471 | +20.1% | 0.00% | 0.0% |
| Q2 2017 | $478,000 | -27.4% | 67,020 | -6.4% | 0.00% | 0.0% |
| Q1 2017 | $658,000 | +117.9% | 71,620 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $302,000 | +2.4% | 74,820 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $295,000 | -10.1% | 76,920 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $328,000 | -7.3% | 76,320 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $354,000 | -47.3% | 76,520 | +14.2% | 0.00% | -50.0% |
| Q4 2015 | $672,000 | +36.9% | 66,987 | +1.8% | 0.00% | +100.0% |
| Q3 2015 | $491,000 | -84.3% | 65,787 | -0.3% | 0.00% | -87.5% |
| Q2 2015 | $3,130,000 | +52.5% | 65,987 | +17.8% | 0.01% | +60.0% |
| Q1 2015 | $2,052,000 | +6.8% | 56,008 | +15.7% | 0.01% | 0.0% |
| Q4 2014 | $1,922,000 | +136.7% | 48,408 | +18.9% | 0.01% | +150.0% |
| Q3 2014 | $812,000 | +49.5% | 40,702 | +1.1% | 0.00% | +100.0% |
| Q2 2014 | $543,000 | +96.7% | 40,271 | +58.7% | 0.00% | 0.0% |
| Q1 2014 | $276,000 | -19.5% | 25,371 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $343,000 | +46.6% | 25,371 | +23.3% | 0.00% | 0.0% |
| Q3 2013 | $234,000 | +66.0% | 20,571 | +2.5% | 0.00% | – |
| Q2 2013 | $141,000 | – | 20,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |